JP2022524993A5 - - Google Patents
Info
- Publication number
- JP2022524993A5 JP2022524993A5 JP2021552604A JP2021552604A JP2022524993A5 JP 2022524993 A5 JP2022524993 A5 JP 2022524993A5 JP 2021552604 A JP2021552604 A JP 2021552604A JP 2021552604 A JP2021552604 A JP 2021552604A JP 2022524993 A5 JP2022524993 A5 JP 2022524993A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- acid sequence
- hla
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025011527A JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813647P | 2019-03-04 | 2019-03-04 | |
| US62/813,647 | 2019-03-04 | ||
| PCT/IB2020/051811 WO2020178742A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011527A Division JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022524993A JP2022524993A (ja) | 2022-05-11 |
| JP2022524993A5 true JP2022524993A5 (enExample) | 2023-03-13 |
Family
ID=72337382
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552604A Withdrawn JP2022524993A (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
| JP2025011527A Active JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025011527A Active JP7825752B2 (ja) | 2019-03-04 | 2025-01-27 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220152105A1 (enExample) |
| EP (1) | EP3935177A4 (enExample) |
| JP (2) | JP2022524993A (enExample) |
| KR (1) | KR20210144740A (enExample) |
| CN (1) | CN113795585B (enExample) |
| AU (1) | AU2020231107A1 (enExample) |
| BR (1) | BR112021017467A2 (enExample) |
| CA (1) | CA3132434A1 (enExample) |
| IL (1) | IL286041A (enExample) |
| MX (1) | MX2021010539A (enExample) |
| SG (1) | SG11202109593SA (enExample) |
| TW (1) | TWI877144B (enExample) |
| WO (1) | WO2020178742A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3551221T2 (ro) | 2016-12-08 | 2022-04-30 | Immatics Biotechnologies Gmbh | Noi receptori de celule T și imunoterapie cu utilizarea acestora |
| MX2021010537A (es) | 2019-03-04 | 2021-12-10 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| US12522644B2 (en) | 2019-03-04 | 2026-01-13 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231693A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| CA3133945A1 (en) | 2019-03-25 | 2020-10-01 | University Health Network | T cell receptors and methods of use thereof |
| CN112239495B (zh) * | 2020-10-29 | 2022-04-12 | 上海药明生物技术有限公司 | 稳定的tcr结构及应用 |
| CN122234182A (zh) * | 2026-05-21 | 2026-06-19 | 北京立康生命科技有限公司 | 一种针对gp100肽的特异性t细胞受体及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2674445C (en) * | 2007-01-12 | 2016-06-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| EP3031916B1 (en) * | 2007-06-11 | 2017-06-07 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| JP2019521080A (ja) * | 2016-04-27 | 2019-07-25 | ユニバーシティ・ヘルス・ネットワーク | ペプチド−ｈｌａ複合体およびその産生方法 |
-
2020
- 2020-03-03 CA CA3132434A patent/CA3132434A1/en active Pending
- 2020-03-03 MX MX2021010539A patent/MX2021010539A/es unknown
- 2020-03-03 BR BR112021017467A patent/BR112021017467A2/pt not_active IP Right Cessation
- 2020-03-03 JP JP2021552604A patent/JP2022524993A/ja not_active Withdrawn
- 2020-03-03 CN CN202080025290.9A patent/CN113795585B/zh active Active
- 2020-03-03 US US17/436,936 patent/US20220152105A1/en active Pending
- 2020-03-03 KR KR1020217031553A patent/KR20210144740A/ko active Pending
- 2020-03-03 WO PCT/IB2020/051811 patent/WO2020178742A1/en not_active Ceased
- 2020-03-03 EP EP20767178.5A patent/EP3935177A4/en active Pending
- 2020-03-03 AU AU2020231107A patent/AU2020231107A1/en active Pending
- 2020-03-03 SG SG11202109593S patent/SG11202109593SA/en unknown
- 2020-03-04 TW TW109107110A patent/TWI877144B/zh active
-
2021
- 2021-09-01 IL IL286041A patent/IL286041A/en unknown
-
2025
- 2025-01-27 JP JP2025011527A patent/JP7825752B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022523971A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| JP2022524992A5 (enExample) | ||
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| Baxevanis et al. | Cancer immunotherapy | |
| JP2022543059A5 (enExample) | ||
| EP2446897A1 (en) | Anti-KIR combination treatments and methods | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| CN107847585A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| CN108138148A (zh) | T细胞的激活和扩增 | |
| JP2022543060A5 (enExample) | ||
| CA3052803A1 (en) | Maximizing t-cell memory and compositions and methods therefor | |
| JP2022543058A5 (enExample) | ||
| WO2020178742A1 (en) | T cell receptors and methods of use thereof | |
| AU2020231694A1 (en) | T cell receptors and methods of use thereof | |
| JP2020533962A5 (enExample) | ||
| JP2023542528A5 (enExample) |